Sex differences in adverse drug reactions: Are women more impacted?
Clémence Lacroix(Inserm), A.‐P. Jonville‐Béra(Université de Tours), Bérenger Largeau(Centre Hospitalier Universitaire de Tours), Anaïs Maurier(Centre Val de Loire), Eve-Marie Thillard(Centre Hospitalier Universitaire de Tours), Joëlle Micallef(Institut de Neurosciences des Systèmes), Milou D. Drici(Centre Hospitalier Universitaire de Nice), Alexandre Destère(Centre Hospitalier Universitaire de Nice)
Cited by 23
Related Papers
Drug‐induced peripheral oedema: An aetiology‐based review
|British Journal of Clinical Pharmacology|2021|82
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic
|European Annals of Otorhinolaryngology Head and Neck Diseases|2020|76
Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database
|Journal of the Neurological Sciences|2019|60
A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock
|Critical Care|2009|53
Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions
|Clinical Pharmacology & Therapeutics|2021|48